Recruiting
Phase 2
Phase 3

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

Sponsor:

Takeda

Code:

NCT05816382

Conditions

Narcolepsy Type 1

Eligibility Criteria

Sex: All

Age: 16 - 70

Healthy Volunteers: Not accepted

Interventions

TAK-861

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information